In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

POC diagnostics company Epocal gets $31mm via Series C

Executive Summary

Canadian diagnostics firm Epocal grossed $31mm through its Series C financing led by new investor Highland Capital Management, which was joined by other backers including Genesys Capital Partners, a returning shareholder. A member of Highland takes a seat on the company's board. Aquilo Partners acted as the placement agent.

Deal Industry
  • In Vitro Diagnostics
  • Medical Devices
  • In Vitro Diagnostics
    • Biosensors
    • Chemistry, Immunoassay
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies